跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
Philippines FDA
/
Novaplatin
Approved
STANDARD
Novaplatin
Chong Kun Dang Pharmaceutical Corp.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
3f4c74354cee700a
Company
Chong Kun Dang Pharmaceutical Corp.
Type
Standard
Approval Details
Approval Id
3f4c74354cee700a
Drug Approval Philippines Name
Novaplatin
Product Name
Novaplatin
Registration Number
DRP-12596
Brand Name
Novaplatin
Generic Name
Oxaliplatin
Dosage Form
Lyophilized Powder for Injection (IV Infusion)
Dosage Strength
100 mg
Manufacturer
Chong Kun Dang Pharmaceutical Corp.
Importer
Medinova Pharmaceutical, Inc.
Distributor
Medinova Pharmaceutical, Inc.
Company Detail Path
/organization/chong-kun-dang-pharmaceutical-corp
Issuance Date
12 September 2022
Expiry Date
12 September 2027
Pharmacologic Category
Antineoplastic Agent (Platinum compound)
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
3f4c74354cee700a
Type
Standard
Back to Philippines FDA Approvals